Browsing Category
Pharma Industry News
4750 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Breakthrough for recurrent bladder cancer: UroGen’s UGN-102 achieves 80.6% 18-month complete response in phase 3 trial
Discover how UroGen Pharma’s UGN-102 could transform bladder cancer treatment with durable results; find out what the Phase 3 ENVISION trial reveals!
Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate
Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here.
Cynata Therapeutics advances stem cell trials with strong financial position in March 2025 quarter
Find out how Cynata Therapeutics is driving innovation in regenerative medicine while maintaining a strong financial runway into 2026!
Aurobindo Pharma’s CuraTeQ Biologics set for major breakthrough as CHMP backs Dazublys cancer biosimilar
CuraTeQ Biologics secures CHMP positive opinion for Dazublys, boosting Aurobindo Pharma’s biosimilar ambitions. Find out how it’s shaping the future of cancer care!
VERAXA Biotech seals $1.64bn SPAC merger to launch Nasdaq oncology powerhouse
Find out how VERAXA Biotech’s $1.64B Nasdaq listing is set to redefine cancer treatment with next-gen antibody therapies.
Game-changer for knee pain? Sun Pharma’s MM-II injection delivers lasting relief, wins FDA fast track
Sun Pharma and Moebius report breakthrough in knee osteoarthritis treatment with MM-II. Learn how this new therapy could reshape pain management.
Eli Lilly’s oral weight-loss pill shakes Novo Nordisk as investors brace for market shift
Novo Nordisk shares drop after Eli Lilly’s oral weight-loss pill shows promise. Analysts see a shifting obesity drug market. What this means for investors.
Roche bets big on America: $50bn to fuel next-gen weight loss drugs and diagnostics boom
Discover how Roche’s $50 billion U.S. investment is transforming pharma R&D, diagnostics, and job creation across eight states and reshaping global exports.
ACIP expands Pfizer’s ABRYSVO vaccine guidance to include at-risk adults aged 50–59
Pfizer's RSV vaccine ABRYSVO now recommended for at-risk adults aged 50–59. Learn what it means for public health and Pfizer’s expanding vaccine portfolio.
Lilly’s oral GLP-1 pill cuts blood sugar and weight without injections—Here’s what the breakthrough data shows
Lilly’s oral GLP-1 drug orforglipron showed strong A1C and weight loss results in Phase 3—find out how it could change diabetes care worldwide.